Gaugene is a series b startup based in China. 1 investor tracked. Status: zombie.
Gaugene is a company headquartered in China. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Gaugene develops ultra-sensitive protein detection technology for in vitro diagnostics (IVD), aiming to provide solutions for early disease screening, diagnosis, and treatment monitoring.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.